Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease

Author:

Hong Xuezhi1,Tang Huiqing2,Wu Limao2,Li Lianda2

Affiliation:

1. Department of Pharmacy, Guangxi Traditional Chinese Medicine College, Nanning, Guangxi, 530031, PRC

2. Institute of Chinese Herb Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310031, PRC

Abstract

Abstract The aim of this investigation was to evaluate the efficacy of Alisma orientalis methanolic extract (AOME) on the experimental nonalcoholic fatty liver disease (NAFLD) induced by high-fat diet. Rats were fed with high-fat diet for six weeks and then gavaged the AOME for another six weeks. Typical pathological symptoms of NAFLD occurred in the high-fat diet rats. Administration with the AOME (150,300 and 600 mg kg−1) markedly decreased the serum and liver lipids; the high level of fasting serum glucose was reduced and insulin resistance was improved. The AOME treatment was also helpful in preventing the oxidative stress by lessening lipid peroxidation and activating antioxidant enzymes. Markers of the liver injury, aminotransferase abnormalities and hepatomegaly were improved and morphological changes, such as liver steatosis, mixed inflammation and collagen deposition, were lessened in rats treated with the AOME. These results suggested that the AOME showed hepatoprotective effects on NAFLD and may be a potential clinical application for treatment of this chronic liver disease.

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

Reference38 articles.

1. Nonalcoholic fatty liver disease;Adams;Can. Med. Assoc. J.,2005

2. Treatment of nonalcoholic fatty liver: present and emerging therapies;Angulo;Semin. Liver. Dis.,2001

3. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis;Caldwell;Am. J. Gastroenterol.,2001

4. Inhibition of the three constituents from Alisma orientalis on formation of urinary calcium oxalate calculus in vitro;Cao;Chin. J. New Drugs,2005

5. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome;Chitturi;Hepatology,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3